Pulmonary Drug Delivery Devices Market – Scope of Report TMR’s report on the global pulmonary drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global pulmonary drug delivery devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pulmonary drug delivery devices market from 2023 to 2031. The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the pulmonary drug delivery devices market. Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pulmonary drug delivery devices market. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global pulmonary drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pulmonary drug delivery devices market. The report delves into the competitive landscape of the global pulmonary drug delivery devices market. Key players operating in the global pulmonary drug delivery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pulmonary drug delivery devices market profiled in this report. Key Questions Answered in Global pulmonary drug delivery devices Market Report • What is the sales/revenue generated by pulmonary drug delivery devices across all regions during the forecast period? • What are the opportunities in the global pulmonary drug delivery devices market? • What are the major drivers, restraints, opportunities, and threats in the market? • Which regional market is set to expand at the fastest CAGR during the forecast period? • Which segment is expected to generate the highest revenue globally in 2031? • Which segment is projected to expand at the highest CAGR during the forecast period? • What are the market positions of different companies operating in the global market? Pulmonary Drug Delivery Devices Market – Research Objectives and Research Approach The comprehensive report on the global pulmonary drug delivery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. The report analyzes the global pulmonary drug delivery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pulmonary drug delivery devices market.

1 Executive Summary 1.1 Market Definition and Scope 1.2 Market Segmentation 1.3 Key Research Objectives 1.4 Research Highlights 2 Assumptions and Research Methodology 3 Executive Summary: Global Pulmonary Drug Delivery Devices Market 4 Market Overview 4.1 Market Segmentation 4.1.1 Segment Definition 4.1.2 Industry Evolution / Developments 4.2 Overview 4.3 Market Dynamics 4.3.1 Drivers 4.3.2 Restraints 4.3.3 Opportunities 4.4 Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, 2023-2031 5 Key Insights 5.1 Pipeline Analysis 5.2 Disease Prevalence & Incidence Rate Globally With Key Countries 5.3 COVID-19 Pandemic Impact on Industry 6 Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type 6.1 Introduction and Definitions 6.2 Key Findings/Developments 6.3 Market Value & Volume Forecast, by Product Type, 2023-2031 6.3.1 Dry Powder Inhalers 6.3.2 Metered Dose Inhalers 6.3.3 Nebulizers 6.4 Market Attractiveness, by Product Type 7 Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application 7.1 Introduction and Definitions 7.2 Key Findings/Developments 7.3 Market Value & Volume Forecast, by Application, 2023-2031 7.3.1 Asthma 7.3.2 COPD 7.3.3 Cystic Fibrosis 7.3.4 Others 7.4 Market Attractiveness, by Application 8 Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel 8.1 Introduction and Definitions 8.2 Key Findings/Developments 8.3 Market Value & Volume Forecast, by Distribution Channel, 2023-2031 8.3.1 Retail Pharmacies 8.3.2 Hospital Pharmacies 8.3.3 E-Commerce 8.4 Market Attractiveness, by Distribution Channel 9 Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region 9.1 Key Findings 9.2 Market Value & Volume Forecast, by Region, 2023-2031 9.2.1 North America 9.2.2 Europe 9.2.3 Asia Pacific 9.2.4 Latin America 9.2.5 Middle East & Africa 9.3 Market Attractiveness, by Region 10 North America Pulmonary Drug Delivery Devices Market Analysis and Forecast 10.1 Introduction 10.1.1 Key Findings 10.2 Market Value & Volume Forecast, by Product Type, 2023-2031 10.2.1 Dry Powder Inhalers 10.2.2 Metered Dose Inhalers 10.2.3 Nebulizers 10.3 Market Attractiveness, by Product Type 10.4 Market Value & Volume Forecast, by Application, 2023-2031 10.4.1 Asthma 10.4.2 COPD 10.4.3 Cystic Fibrosis 10.4.4 Others 10.5 Market Attractiveness, by Application 10.6 Market Value & Volume Forecast, by Distribution Channel, 2023-2031 10.6.1 Retail Pharmacies 10.6.2 Hospital Pharmacies 10.6.3 E-Commerce 10.7 Market Attractiveness, by Distribution Channel 10.8 Market Value & Volume Forecast, by Country, 2023-2031 10.8.1 U.S 10.8.2 Canada 10.9 Market Attractiveness Analysis 10.9.1 By Product Type 10.9.2 By Application 10.9.3 By Distribution Channel 10.9.4 By Country 11 Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast 11.1 Introduction 11.1.1 Key Findings 11.2 Market Value & Volume Forecast, by Product Type, 2023-2031 11.2.1 Dry Powder Inhalers 11.2.2 Metered Dose Inhalers 11.2.3 Nebulizers 11.3 Market Attractiveness, by Product Type 11.4 Market Value & Volume Forecast, by Application, 2023-2031 11.4.1 Asthma 11.4.2 COPD 11.4.3 Cystic Fibrosis 11.4.4 Others 11.5 Market Attractiveness, by Application 11.6 Market Value & Volume Forecast, by Distribution Channel, 2023-2031 11.6.1 Retail Pharmacies 11.6.2 Hospital Pharmacies 11.6.3 E-Commerce 11.7 Market Attractiveness, by Distribution Channel 11.8 Market Value & Volume Forecast, by Country/Sub-region, 2023-2031 11.8.1 Germany 11.8.2 U.K 11.8.3 France 11.8.4 Italy 11.8.5 Spain 11.8.6 Rest of Europe 11.9 Market Attractiveness Analysis 11.9.1 By Product Type 11.9.2 By Application 11.9.3 By Distribution Channel 11.9.4 By Country/Sub-region 12 Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast 12.1 Introduction 12.1.1 Key Findings 12.2 Market Value & Volume Forecast, by Product Type, 2023-2031 12.2.1 Dry Powder Inhalers 12.2.2 Metered Dose Inhalers 12.2.3 Nebulizers 12.3 Market Attractiveness, by Product Type 12.4 Market Value & Volume Forecast, by Application, 2023-2031 12.4.1 Asthma 12.4.2 COPD 12.4.3 Cystic Fibrosis 12.4.4 Others 12.5 Market Attractiveness, by Application 12.6 Market Value & Volume Forecast, by Distribution Channel, 2023-2031 12.6.1 Retail Pharmacies 12.6.2 Hospital Pharmacies 12.6.3 E-Commerce 12.7 Market Attractiveness, by Distribution Channel 12.8 Market Value & Volume Forecast, by Country/Sub-region, 2023-2031 12.8.1 China 12.8.2 Japan 12.8.3 India 12.8.4 Australia & New Zealand 12.8.5 Rest of Asia Pacific 12.9 Market Attractiveness Analysis 12.9.1 By Product Type 12.9.2 By Application 12.9.3 By Distribution Channel 12.9.4 By Country/Sub-region 13 Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast 13.1 Introduction 13.1.1 Key Findings 13.2 Market Value & Volume Forecast, by Product Type, 2023-2031 13.2.1 Dry Powder Inhalers 13.2.2 Metered Dose Inhalers 13.2.3 Nebulizers 13.3 Market Attractiveness, by Product Type 13.4 Market Value & Volume Forecast, by Application, 2023-2031 13.4.1 Asthma 13.4.2 COPD 13.4.3 Cystic Fibrosis 13.4.4 Others 13.5 Market Attractiveness, by Application 13.6 Market Value & Volume Forecast, by Distribution Channel, 2023-2031 13.6.1 Retail Pharmacies 13.6.2 Hospital Pharmacies 13.6.3 E-Commerce 13.7 Market Attractiveness, by Distribution Channel 13.8 Market Value & Volume Forecast, by Country/Sub-region, 2023-2031 13.8.1 Brazil 13.8.2 Mexico 13.8.3 Rest of Latin America 13.9 Market Attractiveness Analysis 13.9.1 By Product Type 13.9.2 By Application 13.9.3 By Distribution Channel 13.9.4 By Country/Sub-region 14 Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast 14.1 Introduction 14.1.1 Key Findings 14.2 Market Value & Volume Forecast, by Product Type, 2023-2031 14.2.1 Dry Powder Inhalers 14.2.2 Metered Dose Inhalers 14.2.3 Nebulizers 14.3 Market Attractiveness, by Product Type 14.4 Market Value & Volume Forecast, by Application, 2023-2031 14.4.1 Asthma 14.4.2 COPD 14.4.3 Cystic Fibrosis 14.4.4 Others 14.5 Market Attractiveness, by Application 14.6 Market Value & Volume Forecast, by Distribution Channel, 2023-2031 14.6.1 Retail Pharmacies 14.6.2 Hospital Pharmacies 14.6.3 E-Commerce 14.7 Market Attractiveness, by Distribution Channel 14.8 Market Value & Volume Forecast, by Country/Sub-region, 2023-2031 14.8.1 GCC Countries 14.8.2 South Africa 14.8.3 Rest of Middle East & Africa 14.9 Market Attractiveness Analysis 14.9.1 By Product Type 14.9.2 By Application 14.9.3 By Distribution Channel 14.9.4 By Country/Sub-region 15 Competition Landscape 15.1 Market Player - Competition Matrix (By Tier and Size of Companies) 15.2 Market Share Analysis, by Company (2022) 15.3 Company Profiles 15.3.1 AstraZeneca Plc 15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength) 15.3.1.2 Product Type Portfolio 15.3.1.3 Financial Overview 15.3.1.4 SWOT Analysis 15.3.1.5 Strategic Overview 15.3.2 Novartis AG 15.3.2.1 Company Overview (HQ, Business Segments, Employee Strength) 15.3.2.2 Product Type Portfolio 15.3.2.3 Financial Overview 15.3.2.4 SWOT Analysis 15.3.2.5 Strategic Overview 15.3.3 Boehringer Ingelheim GmbH 15.3.3.1 Company Overview (HQ, Business Segments, Employee Strength) 15.3.3.2 Product Type Portfolio 15.3.3.3 Financial Overview 15.3.3.4 SWOT Analysis 15.3.3.5 Strategic Overview 15.3.4 GlaxoSmithKline Plc 15.3.4.1 Company Overview (HQ, Business Segments, Employee Strength) 15.3.4.2 Product Type Portfolio 15.3.4.3 Financial Overview 15.3.4.4 SWOT Analysis 15.3.4.5 Strategic Overview 15.3.5 Merck & Co., Inc 15.3.5.1 Company Overview (HQ, Business Segments, Employee Strength) 15.3.5.2 Product Type Portfolio 15.3.5.3 Financial Overview 15.3.5.4 SWOT Analysis 15.3.5.5 Strategic Overview 15.3.6 Teva Pharmaceutical Industries Ltd 15.3.6.1 Company Overview (HQ, Business Segments, Employee Strength) 15.3.6.2 Product Type Portfolio 15.3.6.3 Financial Overview 15.3.6.4 SWOT Analysis 15.3.6.5 Strategic Overview